<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD02170000_2</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P00439</UniProt_ID>
  <Seq_Length>452</Seq_Length>
  <Molecule_Weight>51862</Molecule_Weight>
  <KEGG_ID>hsa:5053</KEGG_ID>
  <Orthology_ID>K00500</Orthology_ID>
  <Catalytic_Mechanism>L-phenylalanine + tetrahydrobiopterin + O(2) = L-tyrosine + 4a-hydroxytetrahydrobiopterin.</Catalytic_Mechanism>
  <Pfam_ID>PF01842:ACT@@PF00351:Biopterin_H</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>3</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Phenylalanine-4-hydroxylase</Alias>
      <Alias>PAH</Alias>
      <Alias>Phenylalanine 4-monooxygenase</Alias>
      <Alias>Phe-4-monooxygenase</Alias>
      <Alias>PheOH</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water.</Detail>
      <Keyword>Monooxygenase activity</Keyword>
      <Ontology_ID>GO:0004497</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an amino acid, organic acids containing one or more amino substituents.</Detail>
      <Keyword>Amino acid binding</Keyword>
      <Ontology_ID>GO:0016597</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4-alpha-hydroxytetrahydrobiopterin.</Detail>
      <Keyword>Phenylalanine 4-monooxygenase activity</Keyword>
      <Ontology_ID>GO:0004505</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with iron (Fe) ions.</Detail>
      <Keyword>Iron ion binding</Keyword>
      <Ontology_ID>GO:0005506</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>241</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>255</Position>
      <Original>Leu</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>213</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>154</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>377</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>39</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>314</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>145</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>53</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>263</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>394</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>265</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>347</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>387</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>344</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>238</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>151</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>322</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>299</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>240</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>204</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>333</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>224</Position>
      <Original>Ile</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>257</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>388</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>183</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>334</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>303</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>342</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>380</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>277</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>42</Position>
      <Original>Lys</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>343</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>239</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>413</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>414</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>390</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>56</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>395</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>366</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>348</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>Leu</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>157</Position>
      <Original>Arg</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>403</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>48</Position>
      <Original>Leu</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>300</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>160</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>67</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>41</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>40</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>46</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>282</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>230</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>304</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>164</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>394</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>211</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>345</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>297</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>55</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>201</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>221</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>169</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>331</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>143</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>430</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>341</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>217</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>231</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>330</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>309</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>206</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>207</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>65</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>349</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>318</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>413</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>212</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>349</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>415</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>386</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>300</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>16</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>65</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>372</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>410</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>407</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>255</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>322</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>218</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>20</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>325</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>311</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>310</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>231</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>242</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>309</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>47</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>276</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>87</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>388</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>395</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>344</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>345</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>92</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>350</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>247</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>194</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>306</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>362</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>357</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>201</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>41</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>104</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>337</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>76</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Arg</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>269</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>277</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>264</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>418</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>280</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>338</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>233</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>341</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>84</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>447</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>205</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>297</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>207</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>408</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>408</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>276</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of phenylalanine, 2-amino-3-phenylpropanoic acid.</Detail>
      <Keyword>L-phenylalanine catabolic process</Keyword>
      <Ontology_ID>GO:0006559</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of any of a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.</Detail>
      <Keyword>Catecholamine biosynthetic process</Keyword>
      <Ontology_ID>GO:0042423</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell.</Detail>
      <Keyword>Neurotransmitter biosynthetic process</Keyword>
      <Ontology_ID>GO:0042136</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of amino acids, organic acids containing one or more amino substituents.</Detail>
      <Keyword>Cellular amino acid biosynthetic process</Keyword>
      <Ontology_ID>GO:0008652</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>16</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSTAVLENPGLGRKLSDFGQETSYIEDNCNQNGAISLIFSLKEEVGALAKVLRLFEENDVNLTHIESRPSRLKKDEYEFFTHLDKRSLPALTNIIKILRHDIGATVHELSRDKKKDTVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVLDNTQQLKILADSINSEIGILCSALQKIK</Protein_Seq>
    <DNA_Seq>CTTCATCGTCGTCCAACTGACCTTGAGTGTTAGTTTCGCGGTAAGTTTGGGTATAAGTGCCACCACCAGTGCCGGCAGTGTAGTCAGTAGTTTGTTGCTGGAAGTCGTTACCGCCAAACTGCGTGTTACCGCCTAGATTAGACTGTGGCTGCTGGCGTTGAGGGAAACCTGCCTGTACGTGAGGCCCTAAAAAGCCAGAGACCTCACTCCCGGGGAGCCAGCATGTCCACTGCGGTCCTGGAAAACCCAGGCTTGGGCAGGAAACTCTCTGACTTTGGACAGGAAACAAGCTATATTGAAGACAACTGCAATCAAAATGGTGCCATATCACTGATCTTCTCACTCAAAGAAGAAGTTGGTGCATTGGCCAAAGTATTGCGCTTATTTGAGGAGAATGATGTAAACCTGACCCACATTGAATCTAGACCTTCTCGTTTAAAGAAAGATGAGTATGAATTTTTCACCCATTTGGATAAACGTAGCCTGCCTGCTCTGACAAACATCATCAAGATCTTGAGGCATGACATTGGTGCCACTGTCCATGAGCTTTCACGAGATAAGAAGAAAGACACAGTGCCCTGGTTCCCAAGAACCATTCAAGAGCTGGACAGATTTGCCAATCAGATTCTCAGCTATGGAGCGGAACTGGATGCTGACCACCCTGGTTTTAAAGATCCTGTGTACCGTGCAAGACGGAAGCAGTTTGCTGACATTGCCTACAACTACCGCCATGGGCAGCCCATCCCTCGAGTGGAATACATGGAGGAAGAAAAGAAAACATGGGGCACAGTGTTCAAGACTCTGAAGTCCTTGTATAAAACCCATGCTTGCTATGAGTACAATCACATTTTTCCACTTCTTGAAAAGTACTGTGGCTTCCATGAAGATAACATTCCCCAGCTGGAAGACGTTTCTCAATTCCTGCAGACTTGCACTGGTTTCCGCCTCCGACCTGTGGCTGGCCTGCTTTCCTCTCGGGATTTCTTGGGTGGCCTGGCCTTCCGAGTCTTCCACTGCACACAGTACATCAGACATGGATCCAAGCCCATGTATACCCCCGAACCTGACATCTGCCATGAGCTGTTGGGACATGTGCCCTTGTTTTCAGATCGCAGCTTTGCCCAGTTTTCCCAGGAAATTGGCCTTGCCTCTCTGGGTGCACCTGATGAATACATTGAAAAGCTCGCCACAATTTACTGGTTTACTGTGGAGTTTGGGCTCTGCAAACAAGGAGACTCCATAAAGGCATATGGTGCTGGGCTCCTGTCATCCTTTGGTGAATTACAGTACTGCTTATCAGAGAAGCCAAAGCTTCTCCCCCTGGAGCTGGAGAAGACAGCCATCCAAAATTACACTGTCACGGAGTTCCAGCCCCTGTATTACGTGGCAGAGAGTTTTAATGATGCCAAGGAGAAAGTAAGGAACTTTGCTGCCACAATACCTCGGCCCTTCTCAGTTCGCTACGACCCATACACCCAAAGGATTGAGGTCTTGGACAATACCCAGCAGCTTAAGATTTTGGCTGATTCCATTAACAGTGAAATTGGAATCCTTTGCAGTGCCCTCCAGAAAATAAAGTAAAGCCATGGACAGAATGTGGTCTGTCAGCTGTGAATCTGTTGATGGAGATCCAACTATTTCTTTCATCAGAAAAAGTCCGAAAAGCAAACCTTAATTTGAAATAACAGCCTTAAATCCTTTACAAGATGGAGAAACAACAAATAAGTCAAAATAATCTGAAATGACAGGATATGAGTACATACTCAAGAGCATAATGGTAAATCTTTTGGGGTCATCTTTGATTTAGAGATGATAATCCCATACTCTCAATTGAGTTAAATCAGTAATCTGTCGCATTTCATCAAGATTAATTAAAATTTGGGACCTGCTTCATTCAAGCTTCATATATGCTTTGCAGAGAACTCATAAAGGAGCATATAAGGCTAAATGTAAAACACAAGACTGTCATTAGAATTGAATTATTGGGCTTAATATAAATCGTAACCTATGAAGTTTATTTTCTATTTTAGTTAACTATGATTCCAATTACTACTTTGTTATTGTACCTAAGTAAATTTTCTTTAGGTCAGAAGCCCATTAAAATAGTTACAAGCATTGAACTTCTTTAGTATTATATTAATATAAAAACATTTTTGTATGTTTTATTGTAATCATAAATACTGCTGTATAAGGTAATAAAACTCTGCACCTAATCCCCATAACTTCCAGTATCATTTTCCAATTAATTATCAAGTCTGTTTTGGGAAACACTTTGAGGACATTTATGATGCAGCAGATGTTGACTAAAGGCTTGGTTGGTAGATATTCAGGAAATGTTCACTGAATAAATAAGTAAATACATTATTGAAAAGCAAATCTGTATAAATGTGAAATTTTTATTTGTATTAGTAATAAAACATTAGTAGTTT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Liver</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Unknown</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PAH</Gene_Name>
    <Gene_ID>5053</Gene_ID>
    <Genbank_ACCN>NM_000277</Genbank_ACCN>
    <Protein_ACCN>NP_000268</Protein_ACCN>
    <HGNC_ID>8582</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5053</Gene_URL>
    <UCSC_ID>uc001tjq.1</UCSC_ID>
    <EMBL_ID>ENSG00000171759</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Mild Hyperphenylalaninemia</Disease_Name>
      <Disease_Detail>Mild Hyperphenylalaninemia</Disease_Detail>
      <Disease_DB>MLD011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mild_hyperphenylalaninemia?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Phenylketonuria</Disease_Name>
      <Disease_Detail>Phenylketonuria</Disease_Detail>
      <Disease_DB>PHN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/phenylketonuria?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tetrahydrobiopterin Deficiency</Disease_Name>
      <Disease_Detail>Tetrahydrobiopterin Deficiency</Disease_Detail>
      <Disease_DB>TTR005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tetrahydrobiopterin_deficiency?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tetrahydrobiopterin-Responsive Hyperphenylalaninemia/phenylketonuria</Disease_Name>
      <Disease_Detail>Tetrahydrobiopterin-Responsive Hyperphenylalaninemia/phenylketonuria</Disease_Detail>
      <Disease_DB>TTR020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tetrahydrobiopterin_responsive_hyperphenylalaninemia_phenylketonuria?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dihydropteridine Reductase Deficiency</Disease_Name>
      <Disease_Detail>Dihydropteridine Reductase Deficiency</Disease_Detail>
      <Disease_DB>DHY007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dihydropteridine_reductase_deficiency?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Psychotic Disorder</Disease_Name>
      <Disease_Detail>Psychotic Disorder</Disease_Detail>
      <Disease_DB>PSY004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/psychotic_disorder?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Benign Hyperphenylalaninemia</Disease_Name>
      <Disease_Detail>Benign Hyperphenylalaninemia</Disease_Detail>
      <Disease_DB>BNG040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/benign_hyperphenylalaninemia?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Maternal Hyperphenylalaninemia</Disease_Name>
      <Disease_Detail>Maternal Hyperphenylalaninemia</Disease_Detail>
      <Disease_DB>MTR016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/maternal_hyperphenylalaninemia?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mevalonic Aciduria</Disease_Name>
      <Disease_Detail>Mevalonic Aciduria</Disease_Detail>
      <Disease_DB>MVL001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mevalonic_aciduria?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tyrosinemia</Disease_Name>
      <Disease_Detail>Tyrosinemia</Disease_Detail>
      <Disease_DB>TYR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tyrosinemia?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hyperphenylalaninemia</Disease_Name>
      <Disease_Detail>Hyperphenylalaninemia</Disease_Detail>
      <Disease_DB>HYP141</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hyperphenylalaninemia?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mild Phenylketonuria</Disease_Name>
      <Disease_Detail>Mild Phenylketonuria</Disease_Detail>
      <Disease_DB>MLD010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mild_phenylketonuria?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Fragile X Syndrome</Disease_Name>
      <Disease_Detail>Fragile X Syndrome</Disease_Detail>
      <Disease_DB>FRG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/fragile_x_syndrome?search=PAH#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Norse</Disease_Name>
      <Disease_Detail>Norse</Disease_Detail>
      <Disease_DB>NRS006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/norse?search=PAH#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND L-DOPA (3,4-DIHYDROXYPHENYLALANINE) INHIBITOR</PDB_Title>
      <PDB_ID>6PAH</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=6PAH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>3,4-DIHYDROXYPHENYLALANINE</Ligand_Name>
      <PubMed_Title>Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution.</PubMed_Title>
      <Author>Erlandsen H, et al.</Author>
      <Journal>Biochemistry. 1998 Nov 10;37(45):15638-46.</Journal>
      <PubMed_ID>9843368</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN PHENYLALANINE HYDROXYLASE DIMER, RESIDUES 117-424</PDB_Title>
      <PDB_ID>1PAH</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=1PAH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria.</PubMed_Title>
      <Author>Erlandsen H, et al.</Author>
      <Journal>Nat Struct Biol. 1997 Dec;4(12):995-1000.</Journal>
      <PubMed_ID>9406548</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Catalytic Domain of Human Phenylalanine Hydroxylase (Fe(II)) in Complex with Tetrahydrobiopterin and Thienylalanine</PDB_Title>
      <PDB_ID>1KW0</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=1KW0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>5,6,7,8-TETRAHYDROBIOPTERIN $BETA(2-THIENYL)ALANINE</Ligand_Name>
      <PubMed_Title>Crystal structure of the ternary complex of the catalytic domain of human phenylalanine hydroxylase with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine, and its implications for the mechanism of catalysis and substrate activation.</PubMed_Title>
      <Author>Andersen OA, et al.</Author>
      <Journal>J Mol Biol. 2002 Jul 26;320(5):1095-108.</Journal>
      <PubMed_ID>12126628</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND ADRENALINE INHIBITOR</PDB_Title>
      <PDB_ID>3PAH</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3PAH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>L-EPINEPHRINE</Ligand_Name>
      <PubMed_Title>Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution.</PubMed_Title>
      <Author>Erlandsen H, et al.</Author>
      <Journal>Biochemistry. 1998 Nov 10;37(45):15638-46.</Journal>
      <PubMed_ID>9843368</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Catalytic Domain of Human Phenylalanine Hydroxylase Fe(II)</PDB_Title>
      <PDB_ID>1J8T</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J8T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High resolution crystal structures of the catalytic domain of human phenylalanine hydroxylase in its catalytically active Fe(II) form and binary complex with tetrahydrobiopterin.</PubMed_Title>
      <Author>Andersen OA, et al.</Author>
      <Journal>J Mol Biol. 2001 Nov 23;314(2):279-91.</Journal>
      <PubMed_ID>11718561</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND NOR-ADRENALINE INHIBITOR</PDB_Title>
      <PDB_ID>4PAH</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=4PAH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>L-NOREPINEPHRINE</Ligand_Name>
      <PubMed_Title>Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution.</PubMed_Title>
      <Author>Erlandsen H, et al.</Author>
      <Journal>Biochemistry. 1998 Nov 10;37(45):15638-46.</Journal>
      <PubMed_ID>9843368</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of ternary complex of the catalytic domain of human phenylalanine hydroxylase (Fe(II)) complexed with tetrahydrobiopterin and norleucine</PDB_Title>
      <PDB_ID>1MMT</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MMT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>5,6,7,8-TETRAHYDROBIOPTERIN $NORLEUCINE</Ligand_Name>
      <PubMed_Title>2.0A resolution crystal structures of the ternary complexes of human phenylalanine hydroxylase catalytic domain with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine or L-norleucine: substrate specificity and molecular motions related to substrate binding.</PubMed_Title>
      <Author>Andersen OA, et al.</Author>
      <Journal>J Mol Biol. 2003 Oct 31;333(4):747-57.</Journal>
      <PubMed_ID>14568534</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>TETRAMERIC HUMAN PHENYLALANINE HYDROXYLASE</PDB_Title>
      <PDB_ID>2PAH</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2PAH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria.</PubMed_Title>
      <Author>Fusetti F, et al.</Author>
      <Journal>J Biol Chem. 1998 Jul 3;273(27):16962-7.</Journal>
      <PubMed_ID>9642259</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of double truncated human phenylalanine hydroxylase BH4-responsive PKU mutant A313T.</PDB_Title>
      <PDB_ID>1TDW</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TDW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.</PubMed_Title>
      <Author>Erlandsen H, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16903-8.</Journal>
      <PubMed_ID>15557004</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of phenylalanine hydroxylase A313T mutant with 7,8-dihydrobiopterin bound</PDB_Title>
      <PDB_ID>1TG2</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TG2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-AMINO-6-(1,2-DIHYDROXY-PROPYL)-7,8-DIHYDRO- 6H-PTERIDIN-4-ONE</Ligand_Name>
      <PubMed_Title>Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.</PubMed_Title>
      <Author>Erlandsen H, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16903-8.</Journal>
      <PubMed_ID>15557004</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of ternary complex of the catalytic domain of human phenylalanine hydroxylase ((FeII)) complexed with tetrahydrobiopterin and thienylalanine</PDB_Title>
      <PDB_ID>1MMK</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MMK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>5,6,7,8-TETRAHYDROBIOPTERIN $BETA(2-THIENYL)ALANINE</Ligand_Name>
      <PubMed_Title>2.0A resolution crystal structures of the ternary complexes of human phenylalanine hydroxylase catalytic domain with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine or L-norleucine: substrate specificity and molecular motions related to substrate binding.</PubMed_Title>
      <Author>Andersen OA, et al.</Author>
      <Journal>J Mol Biol. 2003 Oct 31;333(4):747-57.</Journal>
      <PubMed_ID>14568534</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Catalytic Domain of Human Phenylalanine Hydroxylase Fe(II) in Complex with Tetrahydrobiopterin</PDB_Title>
      <PDB_ID>1J8U</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=1J8U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>5,6,7,8-TETRAHYDROBIOPTERIN</Ligand_Name>
      <PubMed_Title>High resolution crystal structures of the catalytic domain of human phenylalanine hydroxylase in its catalytically active Fe(II) form and binary complex with tetrahydrobiopterin.</PubMed_Title>
      <Author>Andersen OA, et al.</Author>
      <Journal>J Mol Biol. 2001 Nov 23;314(2):279-91.</Journal>
      <PubMed_ID>11718561</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND DOPAMINE INHIBITOR</PDB_Title>
      <PDB_ID>5PAH</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=5PAH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>L-DOPAMINE</Ligand_Name>
      <PubMed_Title>Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution.</PubMed_Title>
      <Author>Erlandsen H, et al.</Author>
      <Journal>Biochemistry. 1998 Nov 10;37(45):15638-46.</Journal>
      <PubMed_ID>9843368</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of binary complex of the catalytic domain of human phenylalanine hydroxylase with dihydrobiopterin (BH2)</PDB_Title>
      <PDB_ID>1LRM</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LRM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>7,8-DIHYDROBIOPTERIN</Ligand_Name>
      <Journal>Not in PubMed</Journal>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko01230</Pathway_ID>
      <Pathway_Title>Biosynthesis of amino acids</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00360</Pathway_ID>
      <Pathway_Title>Phenylalanine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Amino acid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00400</Pathway_ID>
      <Pathway_Title>Phenylalanine, tyrosine and tryptophan biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Amino acid metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.dfb.b.b.c.html</SCOP_URL>
    <CATH_Class>Mainly alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/2pah</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Shiman R, J.Biol.Chem. 1990,265(20):11633-11642.;Jaffe EK, et al. Arch Biochem Biophys. 2013,530(2):73-82.</Site_Reference>
      <Site_Type>Morpheein model</Site_Type>
      <PubMed_ID>2365689;23296088</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.14.16.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/14/16/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD02170001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02170002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02170003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02170004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>